NAGA anticorps (AA 43-329) (FITC)
Aperçu rapide pour NAGA anticorps (AA 43-329) (FITC) (ABIN8012968)
Antigène
Voir toutes NAGA AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 43-329
-
Fonction
- Anti-NAGA Antibody FITC Conjugated
-
Réactivité croisée (Details)
- No cross-reactivity with other proteins
-
Homologie
- Human NAGAshares 86.7%,85.4% amino acid (aa) sequence identity with mouse,rat NAGA,respectively.
-
Purification
- Immunogen affinity purified.
-
Immunogène
- E.coli-derived human NAGA recombinant protein (Position: D43-R329). Human NAGAshares 86.7% and 85.4% amino acid (aa) sequence identity with mouse and rat NAGA, respectively.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Date de péremption
- 12 months
-
-
- NAGA (N-Acetylgalactosaminidase, alpha (NAGA))
-
Autre désignation
- NAGA
-
Sujet
-
Background: NAGA encodes the lysosomal enzyme alpha-N-acetylgalactosaminidase, which cleaves alpha-N-acetylgalactosaminyl moieties from glycoconjugates. Mutations in NAGA have been identified as the cause of Schindler disease types I and II (type II also known as Kanzaki disease).
Gene Full Name: alpha-N-acetylgalactosaminidase
-
ID gène
- 4668
-
UniProt
- P17050
Antigène
-